As a consequence, (v) this cadherin switch, especially the increase of VE-cadherin in combination with a loss of E-cadherin, enables breast cancer cells to integrate into endothelial tubes without significant loss of vessel integrity and barrier function. Here, CDH17 is linked to breast carcinoma.